Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Natural products show promise for treating diseases but need more research to understand and use them effectively.

New steroid compounds may help with hormonal therapy and have potential benefits for glucose disorders, but more research is needed.

Estrogen loss during menopause worsens skin health, but hormone replacement therapy may improve it, though more research is needed.

Hormone therapy for breast cancer often leads to sexual issues like vaginal dryness and decreased libido.

Estrogen increases a growth factor in hair cells which might affect hair loss.

Gene variant linked to prostate cancer, hormone levels, and hair loss.

The document suggests that blocking sweat glands with antiperspirants might allow skin-generated hormones to be absorbed, possibly increasing breast and prostate cancer risk.

Targeting vitamin D and androgen receptors may effectively treat triple-negative breast cancer, especially with chemotherapy.

Androgen receptor inactivation delays skin cancer onset and reduces incidence in mice, with gender differences in susceptibility.

Vitamin D and estrogen may help protect heart and kidney health, and maintaining sufficient vitamin D levels could be especially beneficial for African Americans, postmenopausal women, and people with chronic kidney disease.

KRT17 may be a new target for endometrial cancer treatment because it helps cancer cells move and form new blood vessels.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

New targeted cancer drugs can cause skin side effects, and managing them requires patient education and timely care.

Tissue-derived extracellular vesicles are crucial for cancer diagnosis, prognosis, and treatment.

Topical estrogen helps hair growth in menopausal women with no major side effects.

Ferulic acid may help hair grow by activating certain receptors in cells.

Estrogen Receptor ß (ERß) is the main hormone controller in human skin and hair follicles, not Estrogen Receptor α (ERα) or the Androgen Receptor (AR).

Certain genetic variations in the AR and ERβ genes can affect androgen levels in women.

E211 G>A gene linked to lower risk of severe prostate cancer and hair loss.

A breast cancer patient had lasting hair loss after chemotherapy, which improved with minoxidil treatment.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

Chemotherapy significantly lowers Inhibin A levels in breast cancer patients.

A protein called CBP is found in prostate cancer and can increase the effectiveness of certain prostate cancer treatments.

TGFβ's manipulation of inflammation and immune cells affects cancer spread, suggesting new treatment strategies and biomarkers.

RANK is a key target in breast cancer treatment due to its role in tumor growth and bone metastasis.

Men with frontal male pattern baldness may have a higher risk of gastric cancer.

Higher DHT in male baldness may protect against prostate cancer.

Finasteride use may increase the risk of male breast cancer.

A man developed male breast cancer after four years of finasteride treatment for an enlarged prostate.

Capivasertib improves survival in certain breast cancer cases but requires careful management of side effects.